The expert panel developed guidance statements to offer a general understanding of the context and why it is important to address the specific needs of women. These guidance statements provide information about sex and gender differences, women's experiences, and delivery of substance use treatment and recovery services. The statements are meant to help providers understand how women's experiences impact their recovery, regardless of service delivery setting. Women are diverse, and their individual cultural backgrounds, family histories, and life experiences influence their treatment and recovery needs. The guidance statements are based on experiences and characteristics frequently seen among women and will help providers better respond to and serve women in their centers. These statements serve as overarching concepts that guide the more specific practices and strategies described in the next section.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

Unique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies, Psychopharmacology is appropriate for undergraduates studying the relationships between the behavioral effects of psychoactive drugs and their mechanisms of action. 1. Chapter-opening vignettes foster student engagement 2. Breakout boxes present novel, and, in some cases, controversial topics for special discussion. Box themes include: History of Psychopharmacology; Pharmacology in Action; Clinical Applications; Of Special Interest; and The Cutting Edge. 3. The book is extensively illustrated with full-color photographs and line art depicting important concepts and experimental data 4. Section Summaries highlight key concepts from the section of text just read 5. Chapter-ending Recommended Readings offer suggestions for further study And the enhanced eBook provides an interactive learning pathway through the content. Meyer, Psychopharmacology and it's accompanying enhanced ebook provide engaging features like self-study questions, and clinical case studies, cutting edge research, and applied pharmacology to keep students focused on the content, while providing the scientific depth, breadth, and rigor required for the course.

Work on female drinking and female drug and alcohol abuse is proliferating because interest and productivity in alcohol research has expanded. In this work, the editors' primary focus is on the abuse of alcohol, its biological effects, behavioral effects, abuses, and problems. This book updates where this field is at the moment. The first five chapters deal with basic issues of biology, epidemology, and anthropology. The next five chapters deal with substance abuse including antecedents, consequences, comorbidity, fetal effects, special populations, and illicit drug use. Two chapters which follow are concerned with related disorders, that is, smoking and eating disorders. The final chapters cover treatment and prevention.